Author

Masaaki Inoue

ORCID: 0009-0003-7830-5082

Observed ORCID: 0009-0003-7830-5082

OpenAlex ID: A5146834043

Table 1 from Clinical Characteristics and Spatial Transcriptome Analysis of Non–Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study

2026 · Tadahiro Kuribayashi, Go Makimoto, et al.

Figure 2 from Clinical Characteristics and Spatial Transcriptome Analysis of Non–Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study

2026 · Tadahiro Kuribayashi, Go Makimoto, et al.

Figure S5 from Clinical Characteristics and Spatial Transcriptome Analysis of Non–Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study

2026 · Tadahiro Kuribayashi, Go Makimoto, et al.

Supplementary Table from Clinical Characteristics and Spatial Transcriptome Analysis of Non–Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study

2026 · Tadahiro Kuribayashi, Go Makimoto, et al.

Table 3 from Clinical Characteristics and Spatial Transcriptome Analysis of Non–Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study

2026 · Tadahiro Kuribayashi, Go Makimoto, et al.

Figure 3 from Clinical Characteristics and Spatial Transcriptome Analysis of Non–Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study

2026 · Tadahiro Kuribayashi, Go Makimoto, et al.

Figure S3 from Clinical Characteristics and Spatial Transcriptome Analysis of Non–Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study

2026 · Tadahiro Kuribayashi, Go Makimoto, et al.

Figure S2 from Clinical Characteristics and Spatial Transcriptome Analysis of Non–Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study

2026 · Tadahiro Kuribayashi, Go Makimoto, et al.

Table 2 from Clinical Characteristics and Spatial Transcriptome Analysis of Non–Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study

2026 · Tadahiro Kuribayashi, Go Makimoto, et al.

Figure S1 from Clinical Characteristics and Spatial Transcriptome Analysis of Non–Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study

2026 · Tadahiro Kuribayashi, Go Makimoto, et al.

Figure 1 from Clinical Characteristics and Spatial Transcriptome Analysis of Non–Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study

2026 · Tadahiro Kuribayashi, Go Makimoto, et al.

Data from Clinical Characteristics and Spatial Transcriptome Analysis of Non–Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study

2026 · Tadahiro Kuribayashi, Go Makimoto, et al.

Figure S4 from Clinical Characteristics and Spatial Transcriptome Analysis of Non–Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study

2026 · Tadahiro Kuribayashi, Go Makimoto, et al.

Works count: 13

Citation count:

H-index:

I10-index: